Localized lipoatrophy and inadvertent subcutaneous administration of a COVID-19 vaccine

A 60-year-old woman presented with a depressed lesion at the site of her first COVID-19 (Astra Zeneca) vaccine injection. The lesion was diagnosed as a case of injection related localized lipoatrophy as markers of autoimmune disease were negative and biopsy differentiated it from localized involutio...

Descripción completa

Detalles Bibliográficos
Autor principal: Cook, Ian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196709/
https://www.ncbi.nlm.nih.gov/pubmed/35258436
http://dx.doi.org/10.1080/21645515.2022.2042136
Descripción
Sumario:A 60-year-old woman presented with a depressed lesion at the site of her first COVID-19 (Astra Zeneca) vaccine injection. The lesion was diagnosed as a case of injection related localized lipoatrophy as markers of autoimmune disease were negative and biopsy differentiated it from localized involutional lipoatrophy. This case of localized lipoatrophy was likely due to inadvertent subcutaneous injection of the COVID-19 vaccine with a 16 mm long needle.

Ejemplares similares